from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2266/cyp124

LFCtreatmentdescriptionclass of inhibitor

1.589

Amikacinug/mL Amikacintranslation

1.441

Cap5-10ug/mL Capreomycintranslation

2.179

Rox10-50 ug/mL Roxithromycintranslation

0.228

SM2-5 ug/mL Streptomycintranslation

0.931

Tet5-10 ug/mL Tetracyclinetranslation

-0.208

Rif0.2-5ug/mL Rifampicintranscription

0.085

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.272

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.648

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.067

CPZ10-50 ug/mL Chlorpromazinerespiration

1.282

Clofazimine10-13 ug/mL Clofaziminerespiration

0.617

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.140

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.613

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.110

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.898

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.295

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.252

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.743

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.182

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.231

Nigericin50 uM Nigericinrespiration

0.249

TRC10-150 ug/mL Triclosanrespiration

1.804

TRZ10-25 ug/mL Thioridazinerespiration

1.492

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.647

menadione6-10 ug/mL Menadionerespiration

-0.655

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.355

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.848

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.623

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.290

NRP_1Non-replicating persistence stage 1dosRassociated

-0.470

Amp0.2mg/mL AmpicillincellWall

-0.548

Cephalexin20-100 ug/mL CephalexincellWall

-0.353

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.401

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.084

EMB10-20 ug/mL EthambutolcellWall

-0.214

Eta12-40 ug/mL EthionamidecellWall

-0.189

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.798

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.950

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.276

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.092

BZA0.12 mg/mL BenzamidearomaticAmides

-0.175

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.316

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.213

H2O24 mM hydrogen peroxideDNAdamaging

-0.460

Levo10 ug/mL LevofloxacinDNAdamaging

-0.321

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.466

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.789

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.524

UVUV-irradiationDNAdamaging

-0.268

ARP41-4 ug/mL Antitubercular compound ARP4?

0.392

Antimycin12.5-50 ug/mL Antimycin A?

-0.461

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.103

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.040

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.629

PA8240.2-2 ug/mL PA-824?

-0.363

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.689

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.108

Verapamil50 uM Verapamil?

-0.434

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.340

methoxatin10-20 ug/mL Methoxatin?